$HLN

Haleon plc

$9.13
+0.10 (+1.11%) Today
Loading chart…

About Haleon plc

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. Haleon plc was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. The company was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

CEO
Mr. Brian James McNamara
Employees
24,535
Headquarters
Weybridge, United Kingdom
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Website
haleon.com

Key stats

Market Cap
$40.31B
Enterprise Value
$48.01B
P/E Ratio
18.63
EPS (TTM)
$0.49
Beta
0.25
52-Week Range
$8.65 – $11.28
Day's Range
$9.05 – $9.15
Previous Close
$9.03
Volume
7.92M
Avg Volume (3M)
8.62M
Total Cash
$1.35B
Total Debt
$8.63B
Dividend Yield
2.11%
Next Earnings
Feb 25, 2026
Sector
Healthcare

Fundamentals as of Jun 13, 2026

Loading options, flow & filings…